Fluor Faces Class Action Over NuScale's $495M ENTRA1 Deal That Wiped Out 70% of SMR Stock

NuScale Power Corporation ($SMR) shareholders have filed a securities class action lawsuit against Fluor Corporation, alleging the engineering giant failed to properly oversee a controversial $495 million payment to a newly-formed entity that triggered a devastating 70% stock collapse. The lawsuit, filed by Levi & Korsinsky, LLP, centers on Fluor's role as NuScale's largest shareholder and board influencer during a period when the small modular reactor (SMR) developer made material misrepresentations about its commercialization strategy and a key partner's qualifications.

The ENTRA1 Transaction and Market Fallout

The crisis began when NuScale disclosed a $495 million payment to ENTRA1 Energy LLC, a newly-formed entity with questionable credentials and experience in the nuclear sector. The transaction coincided with a $532 million quarterly net loss, signaling severe financial distress at the SMR developer. Following these disclosures on November 6, 2025, NuScale shares plummeted dramatically, erasing approximately 70% of shareholder value during the class period spanning May 13, 2025 through November 6, 2025.

The complaint alleges that Fluor, despite holding substantial equity stakes and board influence over NuScale, failed to implement adequate oversight mechanisms to prevent:

• Misrepresentations regarding ENTRA1's qualifications and nuclear industry experience
• Misleading statements about NuScale's commercialization timeline and strategic direction
• Material omissions about the financial viability of the partnership arrangement
• Inadequate disclosure of risks associated with the ENTRA1 transaction

This oversight failure reportedly allowed management to proceed with the transaction without proper due diligence or shareholder scrutiny, exposing investors to catastrophic losses.

Market Context: SMR Sector Under Pressure

The NuScale collapse occurs against a challenging backdrop for the advanced nuclear sector. Small modular reactors have long been heralded as a transformative solution for decarbonization, attracting significant venture capital and government support. However, the reality of commercialization has proven far more difficult than anticipated, with cost overruns, timeline delays, and technological obstacles plaguing the sector.

NuScale had previously faced setbacks, including the cancellation of its flagship Carbon Free Power Project partnership with Utah Associated Municipal Power Systems (UAMPS) in 2023. That failure prompted a strategic pivot, with management seeking alternative commercial partnerships and revenue streams—a context that made the ENTRA1 deal appear potentially desperate to industry observers.

The broader SMR ecosystem includes competitors like X-energy, TerraPower (backed by Bill Gates), and international players, all racing to achieve first-mover advantage. However, NuScale's public market status ($SMR trades on the NYSE) made it uniquely exposed to shareholder litigation and regulatory scrutiny compared to private peers.

Control Person Liability and Fluor's Exposure

The lawsuit's focus on Fluor Corporation as a "control person" under securities law reflects a critical corporate governance failure. Fluor, one of the world's largest engineering and construction firms, acquired its stake in NuScale as part of a broader strategic bet on advanced nuclear technology. However, holding significant equity and board representation creates legal obligations to ensure management acts in shareholder interests.

Control person liability typically requires proving that the defendant:

• Possessed the power to control or influence the company's actions
• Knew or reasonably should have known of the misstatements or omissions
• Failed to take appropriate steps to prevent or correct the violations

If successful, shareholders could pursue recovery from Fluor for damages stemming from the $495 million ENTRA1 payment and subsequent stock collapse. This could expose Fluor to significant liability separate from any settlement NuScale might negotiate independently.

Investor Implications and Broader Concerns

For shareholders, this lawsuit underscores the risks of investing in early-stage technology companies with complex corporate structures and related-party transactions. The ENTRA1 deal—involving a payment to a newly-formed entity—represents exactly the type of arrangement that attracts regulatory and investor scrutiny, particularly when conducted by companies facing commercialization challenges.

The 70% stock decline reflects a complete loss of confidence in NuScale's management and strategy. Several investor concerns have likely emerged:

• Financial viability: A $532 million quarterly loss raises questions about the path to profitability
• Capital allocation: The $495 million ENTRA1 payment may represent wasteful deployment of scarce resources
• Strategic clarity: The pivot to ENTRA1 suggests previous commercialization strategies had failed
• Governance oversight: Fluor's apparent inability or unwillingness to prevent the deal suggests inadequate board controls

The April 20, 2026 lead plaintiff deadline provides a window for interested shareholders to join or lead the action. Institutional investors holding SMR shares during the class period likely suffered material losses and may seek to recover damages through the litigation process.

Looking ahead, this case will likely become a cautionary tale for investors evaluating early-stage nuclear and clean energy companies. The intersection of ambitious technology development, complex financing arrangements, and weak governance creates conditions ripe for shareholder value destruction. Whether Fluor can successfully defend its role as a passive financial investor or faces liability as a controlling shareholder will establish important precedent for how courts treat major stakeholders in struggling technology ventures.

The litigation also raises questions about NuScale's future viability and whether the company can recover investor confidence and capital as it attempts to rebuild its commercial strategy without the discredited ENTRA1 partnership.